Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

by Ford JH, Foster SA, Stauffer VL, Ruff DD, Aurora SK, Versijpt J
Published 2018-11-01

Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies

by Stauffer VL, Sides R, Lanteri-Minet M, Kielbasa W, Jin Y, Selzler KJ, Tepper SJ
Published 2018-09-01

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

by Peng X, Ascher-Svanum H, Faries DE, Stauffer VL, Kollack-Walker S, Kinon BJ, Kane JM
Published 2011-04-01

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

by Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K
Published 2012-03-01

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

by Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ
Published 2013-06-01